(Urotoday.com) To kick-off a series of lectures discussing testicular cancer at the inaugural meeting of the Global Society of Rare Genitourinary Tumors (GSRGT) 2020 virtual summit, Dr. Andrea Necchi provided the keynote lecture discussing the management of chemotherapy-resistant germ cell tumors. Dr. Necchi started by highlighting the global incidence and mortality of germ-cell tumors:
(UroToday.com) To discuss the evolution of systemic therapies and the landscape of clinical trials among patients with penile cancer, Dr. Philippe Spiess, the co-Course Director of the Global Society of Rare Genitourinary Tumors (GSRGT) 2020 Virtual Summit, invited Dr. Jad Chahoud, his colleague from the Moffitt Cancer Center.
(UroToday.com) The penile cancer session at the Global Society of Rare Genitourinary Tumors (GSRGT) 2020 Virtual Summit included a discussion for the role of chemotherapy in the perioperative management of patients with penile cancer by Dr. Guru Sonpavde from the Dana-Farber Cancer Institute. Dr. Sonpavde notes that surgery alone for patients with locally advanced disease is […]
(UroToday.com) As part of the penile cancer session at the inaugural Global Society of Rare Genitourinary Tumors (GSRGT) 2020 Virtual Summit, Dr. Maarten Albersen from Belgium discussed aggressive surgical approaches for managing patients with nodal disease. Dr. Albersen notes that risk of nodal metastasis is based on the European Association of Urology (EAU) risk delineation:
(UroToday.com) The Global Society of Rare Genitourinary Tumors (GSRGT) 2020 Virtual Summit included an update on the international registry for penile cancer provided by Dr. Marco Bandini from San Raffaele Hospital in Milan, Italy. According to Dr. Bandini, there are several important questions under consideration, including:
(UroToday.com) One of the most important trials in urologic oncology over the last several years is arguably the InPACT trial in advanced penile cancer. At the 2020 Global Society of Rare Genitourinary Tumors (GSRGT) Virtual Summit, Dr. Curtis Pettaway provided an update on the progress of this landmark trial.
(UroToday.com) To discuss aggressive surgical approaches for primary tumors, Dr. Chris Protzel joined the inaugural Global Society of Rare Genitourinary Tumors (GSRGT) 2020 Virtual Summit. Dr. Protzel notes that treatment of the primary tumor is the key to quality of life for these patients. Barriers to treatment of the primary tumor include fear (30%), social problems […]
Multi-centre intervention studies tackling urinary catheterization and its infectious and non-infectious complications are lacking. To decrease urinary catheterization and, consequently, catheter-associated urinary tract infections (CAUTIs) and non-infectious complications.
To examine available data relating to the surgical management of stress urinary incontinence (SUI) in Australia before, during and after a well-publicised Senate Inquiry into transvaginal mesh use and consider outcomes in the context of global guideline changes.
To assess the pelvic floor function in cervical cancer patients after radical hysterectomy and its relationship with urinary incontinence (UI). Cervical cancer patients who underwent radical hysterectomy were recruited from 18 hospitals in China from January 2012 to March 2015.
